Candel Therapeutics has generated favorable phase 3 data supportive of a BLA submission in prostate cancer. Learn why CADL ...
AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback